Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens. (Q51563657)

From Wikidata

Jump to navigation Jump to search

scientific article published on 27 May 2011

Language	Label	Description	Also known as
English	Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens.	scientific article published on 27 May 2011

Statements

scholarly article

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/21623384

Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens. (English)

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/21623384

1 reference

based on heuristic

inferred from title

immunohistochemistry

1 reference

based on heuristic

inferred from title

squamous cell carcinoma

1 reference

based on heuristic

inferred from title

3

object named as

Camelia S Sima

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/21623384

author name string

Natasha Rekhtman

1

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/21623384

Daphne C Ang

2

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/21623384

William D Travis

4

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/21623384

Andre L Moreira

5

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/21623384

publication date

27 May 2011

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/21623384

Modern Pathology

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/21623384

24

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/21623384

10

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/21623384

1348-1359

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/21623384

https://scigraph.springernature.com/pub.10.1038/modpathol.2011.92

0 references

Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Preoperative histological classification of primary lung cancer: accuracy of diagnosis and use of the non-small cell category

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Carcinoma NOS is a common histologic diagnosis and is increasing in proportion among non-small cell lung cancer histologies

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

A reevaluation of the clinical significance of histological subtyping of non--small-cell lung carcinoma: diagnostic algorithms in the era of personalized treatments

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Subtyping of undifferentiated non-small cell carcinomas in bronchial biopsy specimens.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Suitability of thoracic cytology for new therapeutic paradigms in non-small cell lung carcinoma: high accuracy of tumor subtyping and feasibility of EGFR and KRAS molecular testing

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

P63 in pulmonary epithelium, pulmonary squamous neoplasms, and other pulmonary tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

P63 expression in lung carcinoma: a tissue microarray study of 408 cases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

p63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

A novel five-antibody immunohistochemical test for subclassification of lung carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

The use of P63 immunohistochemistry for the identification of squamous cell carcinoma of the lung.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Pathological diagnosis and classification of lung cancer in small biopsies and cytology: strategic management of tissue for molecular testing

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

TTF-1 expression in pulmonary adenocarcinomas.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Comparison of thyroid transcription factor-1 expression by 2 monoclonal antibodies in pulmonary and nonpulmonary primary tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Progenitor stem cell marker expression by pulmonary carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

TTF-1 expression in ovarian and uterine epithelial neoplasia and its potential significance, an immunohistochemical assessment with multiple monoclonal antibodies and different secondary detection systems.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Thyroid transcription factor-1 expression in breast carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Differences in clinicopathological and biological features between central-type and peripheral-type squamous cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Desmocollin-3: a new marker of squamous differentiation in undifferentiated large-cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Selective expression of S100A7 in lung squamous cell carcinomas and large cell carcinomas but not in adenocarcinomas and small cell carcinomas.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

miR-205 Expression levels in nonsmall cell lung cancer do not always distinguish adenocarcinomas from squamous cell carcinomas.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

AIS is an oncogene amplified in squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

The fine structure of large cell undifferentiated carcinoma of the lung. Evidence for its relation to squamous cell carcinomas and adenocarcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Large cell carcinoma of the lung: an endangered species?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Frequent ALK rearrangement and TTF-1/p63 co-expression in lung adenocarcinoma with signet-ring cell component.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

21 January 2018

Treatment-by-Histology Interaction Analyses in Three Phase III Trials Show Superiority of Pemetrexed in Nonsquamous Non-small Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathologic Diagnosis of Advanced Lung Cancer Based on Small Biopsies and Cytology: A Paradigm Shift

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

7 January 2021

based on heuristic

inferred from DOI database lookup

Morphology and a limited number of immunohistochemical markers may efficiently subtype non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohistochemical subtyping of nonsmall cell lung cancer not otherwise specified in fine-needle aspiration cytology: a retrospective study of 103 cases with surgical correlation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of p63, keratin 5/6, keratin 7, and surfactant-A in non-small cell lung carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

7 January 2021

based on heuristic

inferred from DOI database lookup

Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid multiplex immunohistochemistry using the 4-antibody cocktail YANA-4 in differentiating primary adenocarcinoma from squamous cell carcinoma of the lung.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

7 January 2021

based on heuristic

inferred from DOI database lookup

TTF-1, cytokeratin 7, 34betaE12, and CD56/NCAM immunostaining in the subclassification of large cell carcinomas of the lung

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.92

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/MODPATHOL.2011.92

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/21623384

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/21623384

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51563657&oldid=2009710001"